SCHEMBL30641206

SCHEMBL30641206

Cc1ccnc(Nc2c(F)cccc2Br)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.42
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ PKM P14618 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CDK4 P11802 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ SYK P43405 1/20 0.37
▸ AURKA O14965 1/20 0.37
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26674594 1.00 NPC1 (0.42) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL30641300 0.85 NPC1 (0.43) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL26674581 0.85 NPC1 (0.43) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL26674521 0.82 EGFR (0.38) NPC1SMN1; SMN2RAB9ALMNAJAK1
SCHEMBL2229315 0.71 NPC1 (0.44) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL91451 0.70 SMN1; SMN2 (0.67) NPC1SMN1; SMN2RAB9ATP53LMNA
SCHEMBL26674738 0.69 ALDH1A1 (0.40) NPC1SMN1; SMN2RAB9APOLBKMT2A
SCHEMBL4624975 0.67 NPC1 (0.65) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL2504479 0.67 SYK (0.46) NPC1SMN1; SMN2RAB9APKMTP53
SCHEMBL29524621 0.67 KDM4E (0.41) SMN1; SMN2TP53KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119894872-A Heteroarenes, pharmaceutical compositions containing heteroarenes, and methods of use thereof 修复治疗公司 2025-04-25 — — CN disclosed
EP-4526293-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Repare Therapeutics Inc. (CA) 2025-03-26 — — EP disclosed
WO-2023220831-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2023-11-23 — — WO disclosed
Send feedback